--- title: Latest News | Hemostemix (4) description: Company news for investors and health professionals (4) --- [![Hemostemix Logos](https://hemostemix.com/hubfs/Hemostemix%20Logos.png)](https://hemostemix.com) - [Patient Information](https://hemostemix.com/investigational-treatment-options) - [Physician Information](https://hemostemix.com/physicians) - ACP-01 Show submenu for ACP-01 - [ACP-01](https://hemostemix.com/acp-autologous-stem-cell-therapy) - [Clinical Research](https://hemostemix.com/clinical-research) - Conditions Show submenu for Conditions - [Cardiovascular Ischemia & Angina](https://hemostemix.com/cardiovascular-ischemia-angina) - [Chronic Limb Ischemia - CLTI](https://hemostemix.com/chronic-limb-threatening-ischemia) - [Peripheral Arterial Disease- PAD](https://hemostemix.com/peripheral-arterial-disease-pad-and-peripheral-ischemia) - [Vascular Dementia](https://hemostemix.com/vascular-dementia) - [Wound Care](https://hemostemix.com/wound-care) - Blog Show submenu for Blog - [Hemostemix Health Hub](https://hemostemix.com/health-hub-blog) - [Hemostemix Video Library](https://hemostemix.com/videolibrary) - [About](https://hemostemix.com/about) - [Patient Information](https://hemostemix.com/investigational-treatment-options) - [Physician Information](https://hemostemix.com/physicians) - ACP-01 Show submenu for ACP-01 - [ACP-01](https://hemostemix.com/acp-autologous-stem-cell-therapy) - [Clinical Research](https://hemostemix.com/clinical-research) - Conditions Show submenu for Conditions - [Cardiovascular Ischemia & Angina](https://hemostemix.com/cardiovascular-ischemia-angina) - [Chronic Limb Ischemia - CLTI](https://hemostemix.com/chronic-limb-threatening-ischemia) - [Peripheral Arterial Disease- PAD](https://hemostemix.com/peripheral-arterial-disease-pad-and-peripheral-ischemia) - [Vascular Dementia](https://hemostemix.com/vascular-dementia) - [Wound Care](https://hemostemix.com/wound-care) - Blog Show submenu for Blog - [Hemostemix Health Hub](https://hemostemix.com/health-hub-blog) - [Hemostemix Video Library](https://hemostemix.com/videolibrary) - [About](https://hemostemix.com/about) ![menu](https://f.hubspotusercontent40.net/hubfs/7479797/menu.png) ![close\_24px](https://7479797.fs1.hubspotusercontent-na1.net/hubfs/7479797/close_24px.svg) [Investor Site](https://investors.hemostemix.com/) ![](https://hemostemix.com/hubfs/Old%20Site%20Files/sublogo.png) ### Hemostemix All Post - [All Post](https://hemostemix.com/latest-news) - [Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations) - [Latest News](https://hemostemix.com/latest-news/tag/latest-news) - [Chronic Limb Threatening Ischemia](https://hemostemix.com/latest-news/tag/chronic-limb-threatening-ischemia) - [Uncategorized](https://hemostemix.com/latest-news/tag/uncategorized) - [Angina](https://hemostemix.com/latest-news/tag/angina) - [Stem Cells](https://hemostemix.com/latest-news/tag/stem-cells) - [Vascular Dementia](https://hemostemix.com/latest-news/tag/vascular-dementia) - Wound Care Search ###### [Hemostemix Boots on the Ground in Florida - October Update](https://hemostemix.com/latest-news/hemostemix-boots-on-the-ground-in-florida-october-update) [Read More](https://hemostemix.com/latest-news/hemostemix-boots-on-the-ground-in-florida-october-update) [Investor Relations](https://hemostemix.com/latest-news/tag/investor-relations), [Latest News](https://hemostemix.com/latest-news/tag/latest-news), [Angina](https://hemostemix.com/latest-news/tag/angina) ###### [Hemostemix Adds the treatment of Refractory Angina to its Phase 1 Basket Protocol](https://hemostemix.com/latest-news/hemostemix-adds-the-treatment-of-refractory-angina-to-its-phase-1-basket-protocol) [Read More](https://hemostemix.com/latest-news/hemostemix-adds-the-treatment-of-refractory-angina-to-its-phase-1-basket-protocol) ###### [Hemostemix Files for Ethics Approval of its Study of Vascular Dementia](https://hemostemix.com/latest-news/hemostemix-files-for-ethics-approval-of-its-study-of-vascular-dementia) [Read More](https://hemostemix.com/latest-news/hemostemix-files-for-ethics-approval-of-its-study-of-vascular-dementia) ###### [Hemostemix’s Insider Lead Order of $330,000 Private Placement](https://hemostemix.com/latest-news/hemostemixs-insider-lead-order-of-330000-private-placement) [Read More](https://hemostemix.com/latest-news/hemostemixs-insider-lead-order-of-330000-private-placement) ###### [Hemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell™) Across Multiple Ischemic and Vascular Indications Simultaneously](https://hemostemix.com/latest-news/hemostemix-files-fda-submission-for-basket-protocol-filing-1517-to-advance-acp-01-vescell-across-multiple-ischemic-and-vascular-indications-simultaneously) [Read More](https://hemostemix.com/latest-news/hemostemix-files-fda-submission-for-basket-protocol-filing-1517-to-advance-acp-01-vescell-across-multiple-ischemic-and-vascular-indications-simultaneously) ###### [Hemostemix to Present its Clinical Data of the Treatment of Severe Angina](https://hemostemix.com/latest-news/hemostemix-to-present-its-clinical-data-of-the-treatment-of-severe-angina) [Read More](https://hemostemix.com/latest-news/hemostemix-to-present-its-clinical-data-of-the-treatment-of-severe-angina) ###### [Hemostemix to Present at Life Science Investor Forum](https://hemostemix.com/latest-news/hemostemix-to-present-at-life-science-investor-forum) [Read More](https://hemostemix.com/latest-news/hemostemix-to-present-at-life-science-investor-forum) ###### [Hemostemix Announces TSXV Approval of Debt Settlement at $0.20 per Share](https://hemostemix.com/latest-news/hemostemix-announces-tsxv-approval-of-debt-settlement-at-0.20-per-share) [Read More](https://hemostemix.com/latest-news/hemostemix-announces-tsxv-approval-of-debt-settlement-at-0.20-per-share) ###### [Hemostemix Announces Private Placement](https://hemostemix.com/latest-news/hemostemix-announces-private-placement-1) [Read More](https://hemostemix.com/latest-news/hemostemix-announces-private-placement-1) ###### [Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company](https://hemostemix.com/latest-news/hemostemix-precerv-inc-retains-chris-mcnorgan-phd-to-license-ncp-01-to-neural-electrode-brain-implant-company) [Read More](https://hemostemix.com/latest-news/hemostemix-precerv-inc-retains-chris-mcnorgan-phd-to-license-ncp-01-to-neural-electrode-brain-implant-company) [2](https://hemostemix.com/latest-news/author/admin/page/2) [3](https://hemostemix.com/latest-news/author/admin/page/3) [4](https://hemostemix.com/latest-news/author/admin/page/4) [5](https://hemostemix.com/latest-news/author/admin/page/5) [6](https://hemostemix.com/latest-news/author/admin/page/6) [![LOGO\_Primary](https://hemostemix.com/hubfs/LOGO_Primary.png)](https://hemostemix.com) Leave us a message Follow Us Copyright © 2026 Hemostemix, Inc [Privacy Policy |](https://hemostemix.com/privacy-policy) [Terms of Service](https://hemostemix.com/sms-terms-of-service)